Literature DB >> 29386711

Endothelial markers in high altitude induced systemic hypertension (HASH) at moderate high altitude.

Uday Yanamandra1, S P Singh2, Sushma Yanamandra3, Deepak Mulajkar4, R S Grewal5, Shashibala Singh6, M Z Ashraf7, Prasanna Reddy8, Velu Nair9.   

Abstract

BACKGROUND: Chronic intermittent hypoxia is known to induce systemic arterial hypertension whereas chronic hypoxia causes pulmonary arterial hypertension. High altitude (HA) induced systemic hypertension (HASH) in previously normotensive lowlanders following acclimatisation and prolonged stay at moderate HA is a commonly encountered medical problem. HASH has been attributed to increased sympathetic discharge. Endothelial dysfunction (ED) is implicated in hypertension in the plains hence this study was conducted in HA. This is relevant especially because of the established role of ED in the aetiopathogenesis of HA illnesses. Since hypoxia may induce ED, we aimed at studying the association of endothelial dysfunction with HASH in temporary residents at HA.
METHODS: In this case-control single-centre study, we evaluated ED, by measuring endothelial molecular markers, soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (VCAM-1), vascular endothelial growth factor (VEGF) and endothelial selectin (E-Selectin) in 24 cases with HASH and 25 age, sex matched normotensive controls at moderate high altitude (11,500 ft).
RESULTS: The levels of sICAM-1 (patients: 214.3 ± 34.2 μg/L, controls: 196.2 ± 28.5 μg/L; p = 0.049) and VCAM-1 (patients 766.1 ± 123.4 ng/mL, controls: 668.6 + 117.6 ng/mL; p = 0.007) were statistically higher in the patient group. However, VEGF and E-Selectin were not significantly different between the groups. sICAM-1 significantly correlated with levels of systolic and diastolic blood pressure (r = 0.401, p = 0.003 and 0.486, p = 0.000) respectively.
CONCLUSION: HASH is associated with endothelial dysfunction in form of raised levels of sICAM-1 and VCAM-1.

Entities:  

Keywords:  Endothelial dysfunction; High altitude; Systemic hypertension

Year:  2017        PMID: 29386711      PMCID: PMC5771704          DOI: 10.1016/j.mjafi.2017.09.010

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  27 in total

1.  Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema.

Authors:  V Pavlicek; H H Marti; S Grad; J S Gibbs; C Kol; R H Wenger; M Gassmann; J Kohl; F E Maly; O Oelz; E A Koller; C Schirlo
Journal:  Eur J Appl Physiol       Date:  2000-04       Impact factor: 3.078

Review 2.  Selectin-carbohydrate interactions and the initiation of the inflammatory response.

Authors:  L A Lasky
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

Review 4.  Noninvasive assessment of endothelial function in clinical practice.

Authors:  Antonio L Arrebola-Moreno; Martin Laclaustra; Juan Carlos Kaski
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2011-11-17

Review 5.  The selectins: vascular adhesion molecules.

Authors:  T F Tedder; D A Steeber; A Chen; P Engel
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

6.  Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans.

Authors:  Jose A L Calbet
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

7.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.

Authors:  K D O'Brien; T O McDonald; A Chait; M D Allen; C E Alpers
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial.

Authors:  Gianfranco Parati; Grzegorz Bilo; Andrea Faini; Barbara Bilo; Miriam Revera; Andrea Giuliano; Carolina Lombardi; Gianluca Caldara; Francesca Gregorini; Katarzyna Styczkiewicz; Antonella Zambon; Alberto Piperno; Pietro Amedeo Modesti; Piergiuseppe Agostoni; Giuseppe Mancia
Journal:  Eur Heart J       Date:  2014-08-26       Impact factor: 29.983

10.  Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation.

Authors:  C C Chen; C L Rosenbloom; D C Anderson; A M Manning
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

View more
  2 in total

Review 1.  Echoes from Gaea, Poseidon, Hephaestus, and Prometheus: environmental risk factors for high blood pressure.

Authors:  Prateek Sharma; Robert D Brook
Journal:  J Hum Hypertens       Date:  2018-06-13       Impact factor: 3.012

2.  Ventilatory parameters at rest after months of stay at 3300 m: A comparison between acclimatized lowlanders and natives at Leh.

Authors:  Shelka Dua; S P Singh; Anuj Chawla; Latika Mohan; Anirban Bhattacharya; D R Basannar
Journal:  Med J Armed Forces India       Date:  2018-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.